Bonk, Inc. BNKK
NASDAQ · United States · Health Technology
$1.90+0.14 (+7.67%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Under the terms of the agreement, the Company has agreed to purchase and retire 26,667 shares of its Series A Preferred Stock ("Preferred Shares") from Core4 for an aggregate purchase price of $4.This strategic transaction marks a major milestone in 's ongoing commitment to capital structure optimization, balance sheet de-risking, and the proactive protection of common shareholder equity value.
Six-Month Total Revenue Reaches $5.5M (Up 6,218% YoY) Operating Expenses Reduced 52.5% ($4.65M vs $9.77M) Total Liabilities Reduced 32% to $4.07M via Strategic Debt Extinguishment Solid $27.52M Net Equity Base with Zero Long-Term Debt TEMPE, AZ / ...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
New Subsidiary Designed to Optimize Recognition of BONK.fun Revenue, Enhance Financial Transparency, and Streamline Future Strategic Partnerships TEMPE, AZ / ACCESS Newswire / July 29, 2026 / Bonk, Inc. (NASDAQ:BNKK), the public vehicle for the BONK ...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.